The effect of pamidronate on lumbar spine bone density and pain in osteoporosis secondary to systemic mastocytosis

British Journal of Rheumatology

Volumn 36, Issue 3, 1997, Pages 393-396

  Marshall, A ^a   Kavanagh, R T ^a   Crisp, A J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Osteoporosis; Pamidronate; Systemic mastocytosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID;

ADULT; ARTICLE; BONE DENSITY; BONE PAIN; CASE REPORT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUMBAR SPINE; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; SYSTEMIC MASTOCYTOSIS; URTICARIA PIGMENTOSA;

ADULT; BONE DENSITY; DIPHOSPHONATES; FEMALE; HUMANS; LUMBAR VERTEBRAE; MALE; MASTOCYTOSIS; MIDDLE AGED; OSTEOPOROSIS; PAIN;

EID: 0030841035     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Travis WD, Li C-Y, Bergstralh EJ, Yam LT, Swee RG. Systemic mast cell disease: analysis of 58 cases and literature review. Medicine 1988;67:345-68.
2. McKenna MJ, Frame B. The mast cell and bone. Clin Orthop 1985;200:226-33.
3. Chines A, Pacifici R, Avioli LV, Teitelbaum SL, Korenblat PE. Systemic mastocytosis presenting as osteoporosis: a clinical and histomorphometric study. J Clin Endocrinol Metab 1991;72:140-4.
4. Graves I, Stechschulte DJ, Morris DC, Lukert BP. Inhibition of mediator release in systemic mastocytosis is associated with reversal of bone changes. J Bone Min Res 1990;5:1113-9.
5. Andrew SM, Freemont AJ. Skeletal mastocytosis. J Clin Pathol 1993;46:1033-5.
6. Harvey JA, Anderson HC, Borek D, Lukert BP. Osteoporosis associated with mastocytosis confined to bone: report of two cases. Bone 1989;10:237-41.
7. Tharp MD. The spectrum of mastocytosis. Am J Med Sci 1985;289:119.
8. Johansson C, Roupe G, Lindstedt G, Mellstrom D. Bone density, bone markers and bone radiological features in mastocytosis. Age Ageing 1996;25:1-7.
9. Watts RA, Scott DGI, Crisp AJ. Mastocytosis and osteoporosis. Br J Rheumatol 1992;31:715.
10. Alexander RR. Disodium cromoglycate in the treatment of systemic mastocytosis involving only bone. Acta Haematol 1985;74:108-10.
11. Libor C, Frisch B, Gazit D, Gepstein R, Hallel T, Mekori YA. Osteoporosis as the sole presentation of bone marrow mastocytosis. J Bone Min Res 1990;5: 871-6.
12. Cundy T, Beneton MHC, Darby AJ, Marshall WJ, Kanis JA. Osteopenia in systemic mastocytosis: natural history and responses to treatment with inhibitors of bone resorption. Bone 1987;8:149-55.
13. Suzuki K, Lees M, Newlands GF, Nagase H, Woolley DE. Activation of precursors for matrix metalloproteinases 1 (interstitial collagenase) and 3 (Stromalysin) by rat mast cell proteinases I and II. Biochem J 1995;305:301-6.
14. Crisp AJ, Roelke MS, Goldring SR, Krane SM. Heparin modulates intracellular cyclic AMP in human trabecular bone cells and adherent rheumatoid synovial cells. Ann Rheum Dis 1984;43:628-34.
15. Crisp AJ. Studies of histamine in the rheumatoid joint. Rheumatol Int 1984;4:125-8.
16. Crisp AJ, Wright JK, Hazleman BL. The effects of heparin, histamine and salmon calcitonin on mouse calvarial bone resorption. Ann Rheum Dis 1986;45: 422-7.
17. Watts RA, Skingle SJ, Bhambhani MM, Pountain G, Crisp AJ. Treatment of Paget's disease of bone with single dose of intravenous pamidronate. Ann Rheum Dis 1993;52:616-8.